Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 9057238, 12 pages
https://doi.org/10.1155/2017/9057238
Research Article

Pharmacokinetics of Caffeic Acid, Ferulic Acid, Formononetin, Cryptotanshinone, and Tanshinone IIA after Oral Administration of Naoxintong Capsule in Rat by HPLC-MS/MS

1Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
2Tianjin Key Laboratory of Phytochemistry and Pharmaceutical Analysis, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
3College of Material Chemistry and Chemical Engineering, Hangzhou Normal University, Hangzhou 310036, China
4Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA

Correspondence should be addressed to Jun Cao; moc.361@19nujoac and Yan-xu Chang; moc.621@xycmct

Received 30 March 2017; Accepted 30 May 2017; Published 5 July 2017

Academic Editor: Nunziatina De Tommasi

Copyright © 2017 Jin Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Songsong, X. Haiyu, and M. Yan, “Characterization and rapid identification of chemical constituents of NaoXinTong capsules by UHPLC-linear ion trap/Orbitrap mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 111, pp. 104–118, 2015. View at Publisher · View at Google Scholar
  2. C. Jun, Y. Q. Lu, H. H. Lv et al., “Protective effects of naoxintong capsule on cerebral ischemia-reperfusion injury in rats,” Chinese Journal of Rehabilitation Theory and Practice, vol. 15, pp. 138–140, 2009. View at Google Scholar
  3. F. Y. Wang, R. F. Qian, L. L. Han R, L. G. Huang, and G. H. Jiang, “Influences of buchang naoxintong on expression of cerebral nitric oxide synthases in rats with focal cerebral ischemia-reperfusion,” Journal of Guangzhou University of Traditional Chinese Medicine, vol. 29, pp. 41–44, 2012. View at Google Scholar
  4. Q. Zhao, L. L. Yang, and Y. F. Du, “Effect of the Buchang naoxintong capsule on apoptosis of neurons and inflammatory reaction of microglias after acute cerebral ischemia-reperfusion injury in rats,” Journal of Shandong University, vol. 48, pp. 48-49, 2010. View at Google Scholar
  5. H. J. Zhang, Z. X. Zhao, and B. Xia, “The protective mechanism of Naoxintong on cerebral ischemic injury in rats,” Academic Journal of Second Military Medical University, vol. 27, pp. 165–168, 2006. View at Google Scholar
  6. B. Sun, J. Wu, C.-K. Zhou, and S.-K. Fang, “Effects of Buchang Naoxintong on cognitive function and apoptosis of cranial nerve cell in vascular dementia rats induced by chronic ischemia,” Journal of Jilin University Medicine Edition, vol. 33, no. 2, pp. 219–222, 2007. View at Google Scholar · View at Scopus
  7. Q. J. Guo and Y. Shi, “Therapeutic efficacy of naoxintong capsules on vascular dementia and effect of it on oxidative stress,” Chinese Pharmaceutical Journal, vol. 24, pp. 262-263, 2013. View at Google Scholar
  8. X. N. Zhong, H. H. Wang, Z. Q. Lu et al., “Effects of, Naoxintong on atherosclerosis and inducible nitric oxide synthase expression in atherosclerotic rabbit,” Chinese Medical Journal, vol. 126, no. 6, pp. 1166–1170, 2013. View at Google Scholar
  9. F. Zhang, B. Huang, Y. Zhao et al., “BNC protects H9c2 cardiomyoblasts from H2O2-induced oxidative injury through ERK1/2 signaling pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 802784, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. J. Zhao, H. Zhu, S. J. Wang et al., “Naoxintong protects against atherosclerosis through lipid-lowering and inhibiting maturation of dendritic cells in LDL receptor knockout mice fed a high-fat diet,” Current Pharmaceutical Design, vol. 19, no. 33, pp. 5891–5896, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. L. X. Li, L. Chen, and H. J. Zhao, “Effect of naoxintong capsule on the vascular endothelial function and the infarct size of patients with acute myocardial infarction,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 32, pp. 1615–1618, 2011. View at Google Scholar
  12. M. Y. Liu, Q. Pan, Y. L. Chen et al., “NaoXinTong Inhibits the Development of Diabetic Retinopathy in db/db Mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 242517, 8 pages, 2015. View at Publisher · View at Google Scholar
  13. H. Chen, Y. Zhang, X. Wu, C. Li, and H. Wang, “In vitro assessment of cytochrome P450 2C19 potential of naoxintong,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 430262, 6 pages, 2012. View at Publisher · View at Google Scholar
  14. G. Li, F. Y. Meng, H. J. Yang, J. Fang, F. Liu, and M. H. Fu, “UPLC simultaneous determination of five components in Naoxintong capsules,” Chinese Journal of Pharmaceutical Analysis, vol. 33, pp. 414–418, 2013. View at Google Scholar
  15. D. Wang, L. S. Sheng, Y. Song, and P. Li, “Determination of eight astragalosides in BuChang naoxintong capsule by HPL-2MS,” Chinese Journal of Natural Medicines, vol. 4, pp. 287–290, 2006. View at Google Scholar
  16. B. Huang, G. Li, Y.-F. Guo et al., “Study on absorption location of four components from Naoxintong capsule,” Zhongguo Zhongyao Zazhi, vol. 38, no. 6, pp. 889–893, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. G.-Z. Xin, L. Cao, Z.-Q. Shi et al., “Direct pharmacokinetic analysis of puqietinone by in vivo microdialysis sampling and turbulent-flow chromatography coupled with liquid chromatography-mass spectrometry,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 899, pp. 127–134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. C.-Y. Chen, L.-W. Qi, L. Yi, P. Li, and X.-D. Wen, “Liquid chromatography-mass spectrometry analysis of macranthoidin B, macranthoidin A, dipsacoside B, and macranthoside B in rat plasma for the pharmacokinetic investigation,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 877, no. 3, pp. 159–165, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Grassi, G. Desideri, G. Croce, S. Tiberti, A. Aggio, and C. Ferri, “Flavonoids, vascular function and cardiovascular protection,” Current Pharmaceutical Design, vol. 15, no. 10, pp. 1072–1084, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Barone, V. Calabrese, and C. Mancuso, “Ferulic acid and its therapeutic potential as a hormetin for age-related diseases,” Biogerontology, vol. 10, no. 2, pp. 97–108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Li, C. Liu, Y. Zhang, S. Mi, and N. Wang, “Pharmacokinetics of ferulic acid and potential interactions with Honghua and clopidogrel in rats,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 562–567, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Yang and M. Qiu, “Cardiovascular Effects of Tanshinone II A and Its Mechanism Research Progress,” Chinese Journal of Arteriosclerosis, vol. 4, pp. 372–374, 2011. View at Google Scholar
  23. Y. Ma, H. Li, Z. Yue et al., “Cryptotanshinone attenuates cardiac fibrosis via downregulation of COX-2, NOX-2, and NOX-4,” Journal of Cardiovascular Pharmacology, vol. 64, no. 1, pp. 28–37, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Li, G. Wang, P. Li, and H. Hao, “Simultaneous determination of tanshinone IIA and cryptotanshinone in rat plasma by liquid chromatography-electrospray ionisation-mass spectrometry,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 826, no. 1-2, pp. 26–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Sato, S. Itagaki, T. Kurokawa et al., “In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid,” International Journal of Pharmaceutics, vol. 403, no. 1-2, pp. 136–138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. B.-Q. Zhang, S.-J. Hu, L.-H. Qiu et al., “Effects of Astragalus membranaceus and its main components on the acute phase endothelial dysfunction induced by homocysteine,” Vascular Pharmacology, vol. 46, no. 4, pp. 278–285, 2007. View at Publisher · View at Google Scholar · View at Scopus